Article Information
History
- March 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Pim Sermsaksasithorn1,
- Pravit Asawanonda2,
- Phanupong Phutrakool3,
- Thunnicha Ondee1,
- Pajaree Chariyavilaskul4,
- Sunchai Payungporn5,
- Krit Pongpirul1,6,7,8,* and
- Nattiya Hirankarn9,*
- 1Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 2Division of Dermatology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 3Chulalongkorn Data Management, Research Affairs, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- 4Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
- 5Department of Biochemistry, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand
- 6Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 7Department of Infection Biology & Microbiomes, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK
- 8Clinical and Research Center, Bumrungrad International Hospital, Bangkok, Thailand
- 9Department of Microbiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
- ↵*Corresponding authors: doctorkrit{at}gmail.com, krit.po{at}chula.ac.th and nattiya.h{at}chula.ac.th, nattiyap{at}gmail.com
Posted March 09, 2023.
Efficacy and Safety of Cannabis Transdermal Patch for Alleviating Psoriasis Symptoms: Protocol for a Randomized Controlled Trial (CanPatch)
